ENLV
Enlivex and Mount Sinai Health System Announce Research Collaboration for the Development of Allocetra in Combination with Immune Checkpoint Inhibitors.
In addition to the Sepsis for which it was developed, the drug Allocetra has other applications such as severe patients with Covid 19 '
autoimmune diseases.
Indication Global Market Size Pre Clinical Phase Marketing
Organ failure associated with Sepsis
33B Phase Ib Completed Phase IIb Initiation Q1 2021 ARDS associated with severe/critical COVID-19 / Non-COVID-19 ARDS 11B (COVID)
15B (ARDS) COVID-19 Phase II Ongoing
COVID-19 Phase Ib completed.
goog luck.....
Solid tumors in combination with immune checkpoints 44B Q3 2021
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.